{"title":"口服避孕药和GLP-1激动剂。","authors":"","doi":"10.1136/dtb.2025.000049","DOIUrl":null,"url":null,"abstract":"<p><p><b>Overview of:</b> Faculty of Sexual and Reproductive Healthcare. FSRH statement: Glucagon-like peptide-1 (GLP-1) agonists and oral contraception [online], 2025. Available: https://www.cosrh.org/Public/Documents/FSRH-statement-Glucagon-like-peptide-1-agonists-and-oral-contraception-Feb-2025.aspx [Accessed 26 September 2025].</p>","PeriodicalId":11277,"journal":{"name":"Drug and Therapeutics Bulletin","volume":" ","pages":"8"},"PeriodicalIF":0.0000,"publicationDate":"2025-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Oral contraception and GLP-1 agonists.\",\"authors\":\"\",\"doi\":\"10.1136/dtb.2025.000049\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Overview of:</b> Faculty of Sexual and Reproductive Healthcare. FSRH statement: Glucagon-like peptide-1 (GLP-1) agonists and oral contraception [online], 2025. Available: https://www.cosrh.org/Public/Documents/FSRH-statement-Glucagon-like-peptide-1-agonists-and-oral-contraception-Feb-2025.aspx [Accessed 26 September 2025].</p>\",\"PeriodicalId\":11277,\"journal\":{\"name\":\"Drug and Therapeutics Bulletin\",\"volume\":\" \",\"pages\":\"8\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-12-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Drug and Therapeutics Bulletin\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/dtb.2025.000049\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug and Therapeutics Bulletin","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/dtb.2025.000049","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
Overview of: Faculty of Sexual and Reproductive Healthcare. FSRH statement: Glucagon-like peptide-1 (GLP-1) agonists and oral contraception [online], 2025. Available: https://www.cosrh.org/Public/Documents/FSRH-statement-Glucagon-like-peptide-1-agonists-and-oral-contraception-Feb-2025.aspx [Accessed 26 September 2025].
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
